P. Stetson

577 total citations
8 papers, 462 citations indexed

About

P. Stetson is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, P. Stetson has authored 8 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pharmacology, 2 papers in Pediatrics, Perinatology and Child Health and 2 papers in Oncology. Recurrent topics in P. Stetson's work include Pharmacological Effects and Toxicity Studies (2 papers), Interconnection Networks and Systems (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). P. Stetson is often cited by papers focused on Pharmacological Effects and Toxicity Studies (2 papers), Interconnection Networks and Systems (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). P. Stetson collaborates with scholars based in United States. P. Stetson's co-authors include Bert N. La Du, Cary Hsu, Dragomir Draganov, Scott S. Billecke, Raymond E. Counsell, C. E. Watson, William F. Rayburn, Russell W. Pelham, Mark Cleveland and Keith T. Oldham and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Journal of Pharmacology and Experimental Therapeutics and Alimentary Pharmacology & Therapeutics.

In The Last Decade

P. Stetson

8 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Stetson United States 6 251 122 103 82 72 8 462
Maribel Covas Spain 6 148 0.6× 97 0.8× 48 0.5× 31 0.4× 54 0.8× 6 392
Mitsuaki Maseki Japan 5 80 0.3× 33 0.3× 33 0.3× 96 1.2× 23 0.3× 7 538
Rajeev Gupta India 11 52 0.2× 54 0.4× 24 0.2× 122 1.5× 46 0.6× 15 552
D Deschamps France 12 151 0.6× 15 0.1× 38 0.4× 250 3.0× 28 0.4× 20 732
Sara Deakin Switzerland 16 1.1k 4.3× 550 4.5× 269 2.6× 105 1.3× 364 5.1× 20 1.3k
N. Selvaraj India 15 130 0.5× 25 0.2× 17 0.2× 91 1.1× 18 0.3× 24 588
A. Moncion France 9 83 0.3× 14 0.1× 27 0.3× 147 1.8× 54 0.8× 21 604
Albert Yan‐Wo Chan Hong Kong 11 142 0.6× 10 0.1× 27 0.3× 151 1.8× 28 0.4× 19 510
PG Blain United Kingdom 12 24 0.1× 81 0.7× 15 0.1× 94 1.1× 78 1.1× 18 519
Javid Safa Iran 11 21 0.1× 44 0.4× 87 0.8× 70 0.9× 28 0.4× 26 336

Countries citing papers authored by P. Stetson

Since Specialization
Citations

This map shows the geographic impact of P. Stetson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Stetson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Stetson more than expected).

Fields of papers citing papers by P. Stetson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Stetson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Stetson. The network helps show where P. Stetson may publish in the future.

Co-authorship network of co-authors of P. Stetson

This figure shows the co-authorship network connecting the top 25 collaborators of P. Stetson. A scholar is included among the top collaborators of P. Stetson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Stetson. P. Stetson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Pelham, Russell W., et al.. (2008). Clinical trial: single‐ and multiple‐dose pharmacokinetics of polyethylene glycol (PEG‐3350) in healthy young and elderly subjects. Alimentary Pharmacology & Therapeutics. 28(2). 256–265. 44 indexed citations
2.
Billecke, Scott S., Dragomir Draganov, Raymond E. Counsell, et al.. (2000). Human Serum Paraoxonase (pon1) Isozymes Q and R Hydrolyze Lactones and Cyclic Carbonate Esters. Drug Metabolism and Disposition. 28(11). 1335–1342. 318 indexed citations
3.
Drake, Alan J., et al.. (2000). CGaAs PowerPC FXU. 730–735. 1 indexed citations
4.
Domino, E. F., Elemér K. Zsigmond, Viktória Kovács, G. Fekete, & P. Stetson. (1997). A new route, jet injection for anesthetic induction in children--III. Ketamine pharmacokinetic studies.. PubMed. 35(11). 527–30. 8 indexed citations
5.
Oldham, Keith T., Karen S. Guice, P. Stetson, & Robert R. Wolfe. (1989). Bacteremia-induced suppression of alveolar surfactant production. Journal of Surgical Research. 47(5). 397–402. 17 indexed citations
6.
Rayburn, William F., et al.. (1986). Acetaminophen pharmacokinetics: Comparison between pregnant and nonpregnant women. American Journal of Obstetrics and Gynecology. 155(6). 1353–1356. 63 indexed citations
7.
Gyves, John W., P. Stetson, William D. Ensminger, et al.. (1983). Hepatic Arterial Streptozocin: A Clinical Pharmacologic Study in Patients with Liver Tumors. PubMed. 1(1). 63–68. 5 indexed citations
8.
Patterson, Eugene, P. Stetson, & B R Lucchesi. (1980). Plasma and myocardial tissue concentrations of UM-272 (N,N-dimethylpropranolol) after oral administration in dogs.. Journal of Pharmacology and Experimental Therapeutics. 214(2). 449–453. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026